Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Feb 15, 2019; 11(2): 139-152
Published online Feb 15, 2019. doi: 10.4251/wjgo.v11.i2.139
Published online Feb 15, 2019. doi: 10.4251/wjgo.v11.i2.139
Table 4 Five-year survival according to primary tumor location
| Tumor location, n = 93 | N | % | Survivors at the end of 5 yr (%) |
| Appendix | 3 | 3.2 | 100 |
| Duodenum | 2 | 2.2 | 100 |
| Ileum | 7 | 7.5 | 43 |
| Liver | 2 | 2.2 | 50 |
| Colon | 13 | 14 | 54 |
| Stomach | 29 | 31.2 | 79 |
| Esophagus | 1 | 1.1 | 0 |
| Pancreas | 25 | 26.9 | 48 |
| Periampullary | 7 | 7.5 | 43 |
| Rectum | 4 | 4.3 | 75 |
- Citation: Komaç Ö, Bengi G, Sağol Ö, Akarsu M. C-reactive protein may be a prognostic factor for the whole gastroenteropancreatic neuroendocrine tumor group. World J Gastrointest Oncol 2019; 11(2): 139-152
- URL: https://www.wjgnet.com/1948-5204/full/v11/i2/139.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i2.139